STOCKHOLM, Oct. 29, 2021 /PRNewswire/ -- Lipidor AB (publ) (Nasdaq First North Growth Market: LIPI) today announced that the collaboration agreement with Cannassure Therapeutics has expanded to include a new patent family covering new innovative AKVANO® topical compositions. Lipidor submitted the new patent application to the European Patent Office on 25 October 2021.